BATS

British American Tobacco occupies a position in global capital markets that few companies can claim: it is simultaneously one of the most criticized enterprises on ethical grounds and one of the most structurally defensible businesses in existence. The tobacco industry does not merely benefit from barriers to entry. It benefits from barriers to entry that governments actively reinforce, year after year, through advertising bans, plain packaging laws, and licensing regimes that make it nearly impossible for a new entrant to build a consumer brand from zero. BAT sits at the center of this paradox. The company is regulated into irrelevance in terms of marketing freedom, yet that same regulation cements its dominance by freezing the competitive landscape.

With a market capitalization of approximately GBP 94 billion, revenue of GBP 25.6 billion in FY2025, and a gross profit margin of 83.5%, BAT generates economics that most consumer goods companies can only dream about. The FY2025 results mark a striking recovery: net income reached GBP 7.76 billion, compared to GBP 3.07 billion in FY2024 and a catastrophic loss of GBP 14.37 billion in FY2023 driven by impairment charges on U.S. combustible brands. That impairment cycle, triggered by a reassessment of the carrying value of brands acquired through the 2017 Reynolds American acquisition, has now largely passed through the income statement. What remains is the underlying cash generation machine.

The central analytical question for BAT is not whether the moat exists. It does. The question is whether the moat is migrating. Combustible cigarettes, the traditional core, face terminal secular decline in developed markets. New categories (vapour products under Vuse, heated tobacco under glo, and modern oral nicotine under Velo) represent the strategic bridge. BAT has committed billions to this transition, yet the new categories remain loss-making at the group level and face a fundamentally different competitive dynamic than combustibles. In vapour, BAT competes not only against Philip Morris International and Japan Tobacco but against a fragmented universe of disposable vape manufacturers, many of them unregulated. The structural insight is this: BAT's moat in combustibles is built on regulatory lock-in, but in new categories, regulation has not yet crystallized enough to provide the same protection. The company is racing to establish structural advantages in new categories before the regulatory architecture is finalized, hoping that when the rules do harden, BAT will be on the inside of the moat rather than the outside.